Literature DB >> 17872642

Uterine fibroid embolization: CME update for family physicians.

Antony Raikhlin1, Mark Otto Baerlocher, Murray R Asch.   

Abstract

OBJECTIVE: To review evidence supporting the use of uterine fibroid embolization (UFE) as an alternative to hysterectomy and myomectomy for managing uterine fibroids. QUALITY OF EVIDENCE: MEDLINE was searched using the MeSH terms embolization, therapeutic; leiomyoma; treatment outcome; pregnancy; and clinical trials. Most published studies on use of UFE for management of uterine fibroids provide level II evidence. MAIN MESSAGE: For 71% to 92% of patients, UFE is effective at alleviating fibroid-related symptoms. After UFE, fibroids are reduced in size by 42% to 83%. Patients' satisfaction with the procedure is high (>90%), and UFE is safe and has a low rate of major complications (1.25%). When compared with hysterectomy, UFE is associated with fewer major complications, shorter hospital stays, and faster recovery. Although successful pregnancy following UFE is possible, there is insufficient evidence to advocate use of UFE over myomectomy for management of uterine fibroids in women wishing to preserve fertility.
CONCLUSION: For treatment of symptomatic uterine fibroids, UFE is a safe and effective nonsurgical alternative to hysterectomy and myomectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17872642      PMCID: PMC1949124     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  52 in total

1.  Massive vaginal hemorrhage after uterine fibroid embolization.

Authors:  Robert K Kerlan; James O Coffey; Marilyn S Milkman; Jeanne M LaBerge; Mark W Wilson; Kristen A Cea Wolanske; Roy L Gordon
Journal:  J Vasc Interv Radiol       Date:  2003-11       Impact factor: 3.464

2.  Uterine artery embolization for fibroid disease is not experimental.

Authors:  Robert L Worthington-Kirsch
Journal:  Cardiovasc Intervent Radiol       Date:  2005 Mar-Apr       Impact factor: 2.740

3.  Arterial embolisation to treat uterine myomata.

Authors:  J H Ravina; D Herbreteau; N Ciraru-Vigneron; J M Bouret; E Houdart; A Aymard; J J Merland
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

4.  Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients.

Authors:  G P Siskin; B F Stainken; K Dowling; P Meo; J Ahn; E G Dolen
Journal:  J Vasc Interv Radiol       Date:  2000-03       Impact factor: 3.464

5.  Uterine artery embolization for the treatment of uterine leiomyomata midterm results.

Authors:  S C Goodwin; B McLucas; M Lee; G Chen; R Perrella; S Vedantham; S Muir; A Lai; J W Sayre; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

6.  Recurrence of leiomyomata after laparoscopic myomectomy.

Authors:  V Doridot; J B Dubuisson; C Chapron; A Fauconnier; K Babaki-Fard
Journal:  J Am Assoc Gynecol Laparosc       Date:  2001-11

7.  Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial.

Authors:  Gaylene Pron; Eva Mocarski; John Bennett; George Vilos; Andrew Common; Leslie Vanderburgh
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

8.  The effect of placenta previa on neonatal mortality: a population-based study in the United States, 1989 through 1997.

Authors:  Cande V Ananth; John C Smulian; Anthony M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  2003-05       Impact factor: 8.661

9.  The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids.

Authors:  Gaylene Pron; John Bennett; Andrew Common; Jane Wall; Murray Asch; Kenneth Sniderman
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

10.  Serious complications of uterine artery embolization for conservative treatment of fibroids.

Authors:  John F Payne; A F Haney
Journal:  Fertil Steril       Date:  2003-01       Impact factor: 7.329

View more
  2 in total

Review 1.  Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence.

Authors:  Kavous Firouznia; Hossein Ghanaati; Amir Hossein Jalali; Madjid Shakiba
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

2.  Significance of changes in inflammatory parameters following uterine artery embolization in pre-menopausal females.

Authors:  Vasileios Souftas; Dorelia Deuteraiou; Xanthoula Anthoulaki; Anna Chalkidou; Anastasia Bothou; Fotini Gaidatzi; Grigorios Tsypsianis; Georgios Iatrakis; Stefanos Zervoudis; Dimitrios Souftas; Spyridon Michalopoulos; Theodosia Vogiatzaki; George Galazios; Nikolaos Nikolettos; Panagiotis Tsikouras
Journal:  Exp Ther Med       Date:  2020-04-09       Impact factor: 2.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.